222 related articles for article (PubMed ID: 33741268)
1. Serum free light chain assessment in type 1 autoimmune pancreatitis.
Ikemune M; Uchida K; Tsukuda S; Ito T; Nakamaru K; Tomiyama T; Ikeura T; Naganuma M; Okazaki K
Pancreatology; 2021 Apr; 21(3):658-665. PubMed ID: 33741268
[TBL] [Abstract][Full Text] [Related]
2. Identification of serum IFN-α and IL-33 as novel biomarkers for type 1 autoimmune pancreatitis and IgG4-related disease.
Minaga K; Watanabe T; Hara A; Kamata K; Omoto S; Nakai A; Otsuka Y; Sekai I; Yoshikawa T; Yamao K; Takenaka M; Chiba Y; Kudo M
Sci Rep; 2020 Sep; 10(1):14879. PubMed ID: 32938972
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-35 promotes the differentiation of regulatory T cells and suppresses Th2 response in IgG4-related type 1 autoimmune pancreatitis.
Ito T; Tanaka T; Nakamaru K; Tomiyama T; Yamaguchi T; Ando Y; Ikeura T; Fukui T; Uchida K; Nishio A; Okazaki K
J Gastroenterol; 2020 Aug; 55(8):789-799. PubMed ID: 32377945
[TBL] [Abstract][Full Text] [Related]
4. Serum immunoglobulin free light chains and their association with clinical phenotypes, serology and activity in patients with IgG4-related disease.
Martín-Nares E; Saavedra-González V; Fagundo-Sierra R; Santinelli-Núñez BE; Romero-Maceda T; Calderón-Vasquez K; Hernandez-Molina G
Sci Rep; 2021 Jan; 11(1):1832. PubMed ID: 33469111
[TBL] [Abstract][Full Text] [Related]
5. Recent advances in IgG4-related autoimmune pancreatitis.
Yang X; Zhou H; Wang W; Yan C; Ji G
Pathol Res Pract; 2024 May; 257():155331. PubMed ID: 38678849
[TBL] [Abstract][Full Text] [Related]
6. Immunoglobulin G4-Related Disease Responder Index Correlates With the Risk of 1-Year Relapse in Type 1 Autoimmune Pancreatitis.
Rogger TM; De Marchi G; Brozzi L; Amodio A; Orsolini G; de Pretis N; Conti Bellocchi MC; Crinò SF; Gabbrielli A; Ciccocioppo R; Frulloni L
Pancreas; 2021 Jul; 50(6):879-881. PubMed ID: 34347736
[TBL] [Abstract][Full Text] [Related]
7. Value of anti-plasminogen binding peptide, anti-carbonic anhydrase II, immunoglobulin G4, and other serological markers for the differentiation of autoimmune pancreatitis and pancreatic cancer.
Detlefsen S; de Vos JD; Tanassi JT; Heegaard NHH; Fristrup C; Schaffalitzky de Muckadell OB
Medicine (Baltimore); 2018 Aug; 97(31):e11641. PubMed ID: 30075546
[TBL] [Abstract][Full Text] [Related]
8. Autoimmune Pancreatitis and IgG4-Related Disease: The Storiform Discovery to Treatment.
Okazaki K
Dig Dis Sci; 2019 Sep; 64(9):2385-2394. PubMed ID: 31363956
[TBL] [Abstract][Full Text] [Related]
9. Clinical and pathological differences between serum immunoglobulin G4-positive and -negative type 1 autoimmune pancreatitis.
Paik WH; Ryu JK; Park JM; Song BJ; Park JK; Kim YT; Lee K
World J Gastroenterol; 2013 Jul; 19(25):4031-8. PubMed ID: 23840149
[TBL] [Abstract][Full Text] [Related]
10. Biomarkers in autoimmune pancreatitis and immunoglobulin G4-related disease.
Hara A; Watanabe T; Minaga K; Yoshikawa T; Kamata K; Kudo M
World J Gastroenterol; 2021 May; 27(19):2257-2269. PubMed ID: 34040320
[TBL] [Abstract][Full Text] [Related]
11. The association of serum-free light-chain levels with markers of renal function.
Erdem BK; Davran F; Yilmaz VT; Çetinkaya R; Akbas H
Ren Fail; 2015 Jul; 37(6):1057-60. PubMed ID: 26056734
[TBL] [Abstract][Full Text] [Related]
12. Plasmacytoid Dendritic Cells as a New Therapeutic Target for Autoimmune Pancreatitis and IgG4-Related Disease.
Minaga K; Watanabe T; Hara A; Yoshikawa T; Kamata K; Kudo M
Front Immunol; 2021; 12():713779. PubMed ID: 34367181
[TBL] [Abstract][Full Text] [Related]
13. The role of serological biomarkers in the diagnosis and management of autoimmune pancreatitis.
de Pretis N; Amodio A; De Marchi G; Marconato E; Ciccocioppo R; Frulloni L
Expert Rev Clin Immunol; 2022 Nov; 18(11):1119-1124. PubMed ID: 36125384
[TBL] [Abstract][Full Text] [Related]
14. Increase diagnostic accuracy in differentiating focal type autoimmune pancreatitis from pancreatic cancer with combined serum IgG4 and CA19-9 levels.
Chang MC; Liang PC; Jan S; Yang CY; Tien YW; Wei SC; Wong JM; Chang YT
Pancreatology; 2014; 14(5):366-72. PubMed ID: 25278306
[TBL] [Abstract][Full Text] [Related]
15. Pancreatic Solid Focal Lesions: Differential Diagnosis between Autoimmune Pancreatitis and Pancreatic Cancer.
Dite P; Novotny I; Dvorackova J; Kianicka B; Blaho M; Svoboda P; Uvirova M; Rohan T; Maskova H; Kunovsky L
Dig Dis; 2019; 37(5):416-421. PubMed ID: 31079114
[TBL] [Abstract][Full Text] [Related]
16. Current status of type 1 (IgG4-related) autoimmune pancreatitis.
Uchida K; Okazaki K
J Gastroenterol; 2022 Oct; 57(10):695-708. PubMed ID: 35916965
[TBL] [Abstract][Full Text] [Related]
17. The sensitivity and specificity of serum immunoglobulin G and immunoglobulin G4 levels in the diagnosis of autoimmune chronic pancreatitis: Korean experience.
Choi EK; Kim MH; Lee TY; Kwon S; Oh HC; Hwang CY; Seo DW; Lee SS; Lee SK
Pancreas; 2007 Aug; 35(2):156-61. PubMed ID: 17632322
[TBL] [Abstract][Full Text] [Related]
18. N Latex FLC serum free light-chain assays in patients with renal impairment.
Jacobs JF; Hoedemakers RM; Teunissen E; Te Velthuis H
Clin Chem Lab Med; 2014 Jun; 52(6):853-9. PubMed ID: 24406282
[TBL] [Abstract][Full Text] [Related]
19. Utility of serum IgG, IgG4 and carbonic anhydrase II antibodies in distinguishing autoimmune pancreatitis from pancreatic cancer and chronic pancreatitis.
Talar-Wojnarowska R; Gąsiorowska A; Olakowski M; Dranka-Bojarowska D; Lampe P; Śmigielski J; Kujawiak M; Grzegorczyk J; Małecka-Panas E
Adv Med Sci; 2014 Sep; 59(2):288-92. PubMed ID: 25194335
[TBL] [Abstract][Full Text] [Related]
20. The diagnostic significance of serum IgG4 levels in patients with autoimmune pancreatitis: a UK study.
Sadler R; Chapman RW; Simpson D; Soonawalla ZF; Waldegrave EL; Burden JM; Misbah SA; Ferry BL
Eur J Gastroenterol Hepatol; 2011 Feb; 23(2):139-45. PubMed ID: 21287719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
